Total planned funding: $356,553,431
Clear active filters
FHI 360
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
| Nigeria | $114,774,828 |
| Mozambique | $59,620,786 |
| Zambia | $52,025,764 |
| Kenya | $24,397,554 |
| Vietnam | $15,206,294 |
| Botswana | $11,059,397 |
| South Africa | $9,556,888 |
| Tanzania | $8,851,848 |
| Burundi | $8,390,534 |
| Papua New Guinea | $6,189,195 |
| Côte d'Ivoire | $5,438,330 |
| Indonesia | $5,176,155 |
| India | $4,545,700 |
| Asia Regional Program | $3,654,954 |
| Democratic Republic of the Congo | $3,640,000 |
| South Sudan | $2,751,916 |
| Ghana | $2,750,000 |
| Caribbean Region | $2,717,206 |
| Malawi | $2,310,000 |
| Ethiopia | $2,003,800 |
| Rwanda | $1,687,592 |
| Central America Region | $1,646,143 |
| Haiti | $1,560,713 |
| Uganda | $1,468,804 |
| Eswatini | $1,333,737 |
| Namibia | $1,210,293 |
| Angola | $1,085,000 |
| Cameroon | $700,000 |
| Dominican Republic | $500,000 |
| Central Asia Region | $300,000 |
| Lesotho | $0 |
Organizational Types
| NGO | $356,553,431 |
Program Areas
| Care | $110,796,168 |
| Treatment | $100,919,739 |
| Prevention | $97,875,332 |
| Governance and Systems | $25,249,733 |
| Testing | $21,712,459 |
Budget Codes
| HTXS: Treatment: Adult Treatment | $88,432,302 |
| HBHC: Care: Adult Care and Support | $55,792,085 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $52,229,951 |
| HKID: Care: Orphans and Vulnerable Children | $35,951,627 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $29,964,658 |
| HVCT: Testing: HIV Testing and Counseling | $21,712,459 |
| PDTX: Treatment: Pediatric Treatment | $12,487,437 |
| OHSS: Health Systems Strengthening | $10,376,329 |
| HVTB: Care: TB/HIV | $10,273,628 |
| PDCS: Care: Pediatric Care and Support | $8,778,828 |
| HLAB: Laboratory Infrastructure | $7,673,084 |
| HVSI: Strategic Information | $7,200,320 |
| CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $6,861,528 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $5,130,629 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $3,186,497 |
| HMIN: Biomedical Prevention: Injection Safety | $403,324 |
| HMBL: Biomedical Prevention: Blood Safety | $98,745 |
| HTXD: Treatment: ARV Drugs | $0 |